The periorbital region is one of the first areas to show signs of aging, with thin skin, fine lines, puffiness, and dark circles. Croma PhilArt Eye was specifically developed to address these issues through polynucleotide-based regeneration, offering a gentle yet impactful solution for rejuvenating delicate eye skin.
This injectable biostimulator enhances skin quality by stimulating fibroblast activity and promoting hydration. It integrates seamlessly into full-face treatment plans, providing clinics with a high-end, targeted option for eye-area revitalization.
How Croma PhilArt Eye Works and Its Clinical Benefits
Croma PhilArt Eye contains highly purified long-chain polynucleotides derived from European freshwater fish, produced via PN‑HPT® technology. This advanced formulation nourishes the skin’s extracellular matrix, enhances hydration, and scavenges free radicals, creating an optimal environment for collagen and elastin synthesis.
In a rigorous clinical trial, 91% of participants showed visible improvements in fine lines and elasticity after treatment. Practitioners report marked enhancements in under-eye brightness and hydration after just two sessions, with sustained effects seen at three months.
What Are the Benefits of Croma PhilArt
When incorporated into a rejuvenation protocol, PhilArt Croma Eye offers several advantages:
Targeted for Thin, Fragile Skin
The formulation is designed for the delicate eye area, where skin thickness is minimal and risks are higher. This makes it ideal for patients with early signs of aging, puffiness, or crepey texture under the eyes.
Safe and Progressive Results
Croma PhilArt Eye avoids overcorrection and prevents the Tyndall effect. Results develop gradually across 3–4 sessions, improving elasticity and under-eye brightness over time.
Pairs Well with Other Modalities
It integrates seamlessly with microneedling, low-level lasers, or neuromodulators, enhancing overall skin quality without interfering with the results of other treatments.
Treatment Protocol and Injection Considerations
Croma PhilArt Eye is injected using microdroplet or linear threading technique, typically with a 30G needle or micro-cannula. It’s administered into the superficial to mid-dermis, depending on patient need. A treatment plan often includes:
- Three sessions spaced two to three weeks apart
- Maintenance every four to six months
- Post-care involving gentle cold compresses and daily SPF
Due to the vascular nature of the under-eye area, bruising may occur but typically resolves within a few days. Proper injection depth and technique are essential to reduce downtime and maximize the effect.
Safety and Tolerability
Croma PhilArt Eye side effects are minimal. Patients may experience slight redness, swelling, or sensitivity post-injection, which typically subsides within 24-48 hours. No permanent or serious adverse effects have been reported in clinical practice when administered correctly.
The biocompatibility of the polynucleotide formulation makes it well tolerated, even for patients who may not respond well to conventional fillers. This makes the product suitable for a broad range of skin types and ages.
Ideal Patient Profiles
Croma PhilArt Eye is especially beneficial for:
- Patients with fine lines, crepey under-eye texture, or puffiness
- Individuals who want to avoid volumizing injectables
- Patients already undergoing face revitalization who want to target the eye zone without overdoing it
- Those interested in regenerative, non-volumizing aesthetic therapies
It serves as an ideal entry point for younger patients starting preventative care or as part of a layered approach in older clients undergoing broader facial rejuvenation.
Ready to Take On Croma PhilArt Eye?
If you’re looking to enhance your eye rejuvenation offerings, consider exploring the benefits of polynucleotide innovation. This cutting-edge product can help elevate your treatments and provide noticeable results for your clients.
To learn more about our polynucleotide offerings and how they can fit into your practice, visit our Croma PhilArt Eye product page for additional information. We’re here to support your journey in expanding your services.
Takeaways
Croma PhilArt Eye is an advanced biostimulatory injectable formulated specifically for the delicate skin around the eyes. By leveraging polynucleotide technology, it offers subtle yet impactful rejuvenation without adding volume, ideal for patients looking for a refined approach to under-eye care.
Its strong safety profile, compatibility with other aesthetic treatments, and ability to address early aging signs make it an essential addition to any modern aesthetic clinic. For practices aiming to deliver effective under-eye care with minimal downtime, Croma PhilArt Eye brings a unique blend of science, safety, and sophistication.
Frequently Asked Questions (FAQs)
What is Croma treatment for the under eyes?
Croma PhilArt Eye is a regenerative injectable made with polynucleotides designed to improve hydration, elasticity, and skin quality in the under-eye region. Unlike fillers, it stimulates cellular repair rather than adding volume.
How long do the effects of Croma PhilArt Eye last?
The effects of Croma PhilArt Eye typically last for several months, with many patients experiencing results for up to six to twelve months. However, the duration can vary based on individual factors, such as skin condition and metabolism. Regular follow-up treatments can help maintain the desired outcome.
Are there any known Croma PhilArt Eye side effects?
Common side effects include mild redness or swelling at the injection site, which usually resolves within 48 hours. The product’s high purity ensures it is well-tolerated across a variety of skin types.